
- Applied Clinical Trials-05-01-2011
- Volume 20
- Issue 5
Study Completion Times
Improved study completion times represents one of the most critical areas for clinical development organizations. Previous TTC research has demonstrated that paying sites more on a cost per patient basis does not improve study completions times.
Improved study completion times represents one of the most critical areas for clinical development organizations. Previous TTC research has demonstrated that paying sites more on a cost per patient basis does not improve study completions times.
Other variables, such as study and protocol design, or whether a CRO or sponsor directly runs the fieldwork may be important. According to
Still, study design factors such as the number of countries in a study, had clear affects on completion times. There is, however, no difference whether a CRO or sponsor company manages the study. —TTC (for more information, contact
Articles in this issue
over 14 years ago
Applied Clinical Trials Digital Edition - May 2011over 14 years ago
Applied Clinical Trials Digital Edition - May 2011, Supplementover 14 years ago
GCLP: an Industry Perspectiveover 14 years ago
Innovation is in for EU's Healthcare Systemover 14 years ago
Business and News Update May 2011over 14 years ago
Innovation in Ethical Reviewover 14 years ago
Patients are not Schrödinger's Catsover 14 years ago
Protocol Amendments: a Costly Solutionover 14 years ago
ACT Supplement Cover Imageover 14 years ago
Translating Clinical DataNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.